NZ514522A - Chemical compounds and their uses - Google Patents

Chemical compounds and their uses

Info

Publication number
NZ514522A
NZ514522A NZ514522A NZ51452200A NZ514522A NZ 514522 A NZ514522 A NZ 514522A NZ 514522 A NZ514522 A NZ 514522A NZ 51452200 A NZ51452200 A NZ 51452200A NZ 514522 A NZ514522 A NZ 514522A
Authority
NZ
New Zealand
Prior art keywords
disorders
mediated
radiation
damage
chemical compounds
Prior art date
Application number
NZ514522A
Other languages
English (en)
Inventor
Maria Gabriella Santoro
Stanley Michael Roberts
Thierry Uyot
Original Assignee
Charterhouse Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9906587.2A external-priority patent/GB9906587D0/en
Application filed by Charterhouse Therapeutics Ltd filed Critical Charterhouse Therapeutics Ltd
Publication of NZ514522A publication Critical patent/NZ514522A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
NZ514522A 1999-03-22 2000-03-22 Chemical compounds and their uses NZ514522A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9906587.2A GB9906587D0 (en) 1999-03-22 1999-03-22 Chemical compounds and their uses
US12696899P 1999-03-30 1999-03-30
PCT/GB2000/001086 WO2000056341A1 (en) 1999-03-22 2000-03-22 Chemical compounds and their uses

Publications (1)

Publication Number Publication Date
NZ514522A true NZ514522A (en) 2004-03-26

Family

ID=26315321

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ514522A NZ514522A (en) 1999-03-22 2000-03-22 Chemical compounds and their uses

Country Status (7)

Country Link
EP (1) EP1165092A1 (xx)
JP (1) JP2002539264A (xx)
AU (1) AU3665700A (xx)
CA (1) CA2366877A1 (xx)
HK (1) HK1041200A1 (xx)
NZ (1) NZ514522A (xx)
WO (1) WO2000056341A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295055A1 (en) * 1997-06-27 1999-01-07 Kaneka Corporation Heat shock factor activity inhibitor
JP2005511775A (ja) * 2001-12-14 2005-04-28 チャーターハウス セラピューティックス リミテッド 医薬組成物の改良
JP2005511791A (ja) * 2001-12-14 2005-04-28 チャーターハウス セラピューティックス リミテッド 医薬組成物の改良
GB0218261D0 (en) * 2002-08-06 2002-09-11 Charterhouse Therapeutics Ltd Improvements in pharmaceutically useful compounds
US20060240011A1 (en) * 2002-08-14 2006-10-26 Delphine Boulanger Use of nf-kappa b inhibitors for the treatment of mastitis
US8003692B2 (en) * 2007-06-15 2011-08-23 Board Of Regents, The University Of Texas System Methods and compositions to inhibit edema factor and adenylyl cyclase
EP2802329A2 (en) 2012-01-09 2014-11-19 The U.S.A. as represented by the Secretary, Department of Health and Human Services Methods of treating or preventing insulin resistance and associated diseases and conditions
WO2014078350A1 (en) 2012-11-15 2014-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating patients infected with hiv and htlv
GB201317609D0 (en) 2013-10-04 2013-11-20 Cancer Rec Tech Ltd Inhibitor compounds
GB201505658D0 (en) 2015-04-01 2015-05-13 Cancer Rec Tech Ltd Inhibitor compounds
GB201617103D0 (en) 2016-10-07 2016-11-23 Cancer Research Technology Limited Compound

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3375914D1 (en) * 1982-10-07 1988-04-14 Teijin Ltd Novel 5-membered cyclic compounds, process for the production thereof, and pharmaceutical use thereof
US4711895A (en) * 1984-10-22 1987-12-08 Teijin Limited 4-hydroxy-2-cyclopentenone, process for production thereof, pharmaceutical composition comprising it
JPS6244A (ja) * 1985-06-25 1987-01-06 Nippon Iyakuhin Kogyo Kk ２−ハロ−２−シクロペンテノン誘導体及びその製法
US5216183A (en) * 1988-04-19 1993-06-01 Teijin Limited Cyclopentanone/cyclopentenone derivative
JPH07233142A (ja) * 1994-02-23 1995-09-05 Teijin Ltd ２，３，４，４，５―五置換―２―シクロペンテノン類の製造法
GB9418762D0 (en) * 1994-09-16 1994-11-02 Bayer Ag Use of substituted cyclopentane-DI-and-triones
IT1284853B1 (it) * 1996-06-18 1998-05-22 Consiglio Nazionale Ricerche Impiego del 2-ciclopenten-1-one come induttore di hsp70.
IT1289250B1 (it) * 1996-12-13 1998-09-29 Consiglio Nazionale Ricerche Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fattore nf-kb
JP2709807B2 (ja) * 1996-11-01 1998-02-04 富士薬品工業株式会社 ３−クロロ−４−シリルオキシ−２−シクロペンテン−１−オン類の製造法
CA2278938A1 (en) * 1997-03-05 1998-09-11 Takara Shuzo Co., Ltd. Pharmaceutical compounds having a physiological activity such as anticancer action
AU730766B2 (en) * 1997-03-11 2001-03-15 Takara Bio Inc. Cyclopentenone derivative
CA2285316A1 (en) * 1997-03-28 1998-10-08 Nobuto Koyama Therapeutic agent for diabetes mellitus
US6284801B1 (en) * 1997-04-01 2001-09-04 Takara Shuzo Co., Ltd. Antirheumatic agents
WO1999000349A1 (en) * 1997-06-30 1999-01-07 Takara Shuzo Co., Ltd. Cyclopentenone derivatives
CN1123340C (zh) * 1997-07-02 2003-10-08 宝酒造株式会社 抗过敏剂
KR20010022050A (ko) * 1997-07-25 2001-03-15 오미야 히사시 제암제
US6525082B1 (en) * 1997-12-11 2003-02-25 Takara Shuzo Co., Ltd. Apoptosis inducer

Also Published As

Publication number Publication date
JP2002539264A (ja) 2002-11-19
EP1165092A1 (en) 2002-01-02
HK1041200A1 (zh) 2002-07-05
CA2366877A1 (en) 2000-09-28
WO2000056341A1 (en) 2000-09-28
AU3665700A (en) 2000-10-09

Similar Documents

Publication Publication Date Title
YU21401A (sh) Tetrahidropiridoetri
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
CY2538B1 (en) Tetrahydropyrido compounds
WO1999057117A3 (de) Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
NZ514522A (en) Chemical compounds and their uses
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
MY121294A (en) Novel hexanoic acid derivatives.
MX9700885A (es) Nuevas heteroariloxazolidinonas.
WO2001017973A3 (de) Neue herbizide
RU94046411A (ru) Производные витамина д, способ их получения, фармацевтическая композиция на их основе и способ ее получения, способ лечения
AU9744298A (en) Substituted tetrahydronaphthaline and analogous compounds
BG105732A (en) Cell adhesion inhibiting antiinflammatory and immune-suppressive compounds
MXPA02009552A (es) Derivados de imidazopiridina alquilada.
BG104726A (en) Novel derivatives of the dihydroxyhexanoic acid
DE69938192D1 (en) Imidazonaphthyridine
MXPA02009551A (es) Profarmacos de derivados de imidazopiridina.
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
PL365165A1 (en) Tricyclic imidazopyridines
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
GB9923710D0 (en) Chemical compounds
DE60011677D1 (en) Tryptase-inhibitoren
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)